𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined modality therapy for Stage III non-small cell lung carcinoma: Results of treatment and patterns of failure

✍ Scribed by S. Reddy; M.S. Lee; P. Bonomi; S.G. Taylor IV; E. Kaplan; Meryl Gale; L.P. Faber; W. Warren; C.F. Kittle; F.R. Hendrickson


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
885 KB
Volume
24
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Results of combined-modality therapy for
✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Combined modality therapy for locally ad
✍ D. Recine; K. Rowland; S. Reddy; M. S. Lee; P. Bonomi; S. Taylor IV; L. P. Faber πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 691 KB

Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa